Claude Laberge

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

C. Laberge, R. Tanguay, J. Duband, 1990, American journal of human genetics.

Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.

C. Laberge, O. Mamer, R. Gagné, 1982, Clinica chimica acta; international journal of clinical chemistry.